Ilmofosine , CAS No.83519-04-4
在庫あり
SKU
I339713
a PKC inhibitor with efficacy against a variety of cancer cell lines
Ilmofosine is a PKC inhibitor with antineoplastic activity with an IC|50|value of 560 nM. It acts as a competitive inhibitor at the regulatory site of PKC. Ilmofosine has efficacy against various human non-small cell lung, breast, colorectal, ovarian, and renal cell cancers at concentrations of 1-30 μg/mL.
その他の情報
| CAS | 83519-04-4 |
|---|---|
| 同義語 | D04504 | SCHEMBL48829 | SH-MM-lysolecithin | [2-(hexadecylsulfanylmethyl)-3-methoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate | NCGC00165808-01 | NSC601679 | NSC-601679 | BM 41440 | (+-)-Ilmofosine | Q27263125 | Ilmofosina | ILMOFOSINE | Ilmofosine (US |
| 保管条件 | Store at -20°C |
| 入荷 | Ice chest + Ice pads |
| Product Description | Ilmofosine is a PKC inhibitor with antineoplastic activity with an IC|50|value of 560 nM. It acts as a competitive inhibitor at the regulatory site of PKC. Ilmofosine has efficacy against various human non-small cell lung, breast, colorectal, ovarian, and renal cell cancers at concentrations of 1-30 μg/mL. |
| 溶解度 | Soluble in water (10 mg/ml). |
| PubChem CID | 55008 |
| 分子式 | C26H56NO5PS |
レビュー
顧客レビュー
Remind me later